High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma

Tumor Biology

Volumn 33, Issue 5, 2012, Pages 1557-1563

  Yu, Hai Feng ^a,c   Zhao, Gang ^b   Ge, Zhi Jun ^a   Wang, Dao Rong ^c   Chen, Jie ^a,c   Zhang, Yun ^a   Zha, Tian Zhou ^a   Zhang, Kai ^a   Zhang, Miao ^a   Tan, Yong Fei ^a   Zhou, Su Jun ^a   Jiang, Chao ^a  

^a YIXING PEOPLE S HOSPITAL   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

Diagnosis; Gastric adenocarcinoma; Prognosis; RIN1; Survival

Indexed keywords

RAS AND RAB INTERACTOR 1 PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR VOLUME;

EID: 84868121289     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0409-0     Document Type: Article

References (23)

1. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305-15. doi: 10.1016/S0140-6736(03)13975-X.
2. Dcken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39. doi: 10.1097/01.sla.0000149300.28588.23.
3. Zhang B, Cao W, Zhang F, Zhang L, Niu R, Niu Y, Fu L, Hao X, Cao X. Protein interacting with C alpha kinase 1 (PICK1) is involved in promoting tumor growth and correlates with poor prognosis of human breast cancer. Cancer Sci. 2010;101:1536-42. doi: 10.1111/j.1349-7006.2010.01566.x.
4. Han L, Wong D, Dhaka A, Afar D, White M, Xie W, Herschman H, Witte O, Colicelli J. Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci USA. 1997;94:4954-9. PMCID: PMC24612.
5. Tall GG, Barbieri MA, Stahl PD, Horazdovsky BF. Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell. 2001;1:73-82.
6. Barbieri MA, Kong C, Chen PI, Horazdovsky BF, Stahl PD. The SRC homology 2 domain of Rin1 mediates its binding to the epidermal growth factor receptor and regulates receptor endocytosis. J Biol Chem. 2003;278:32027-36. doi: 10.1074/jbc.M304324200.
7. Hu H, Bliss JM, Wang Y, Colicelli J. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol. 2005;15:815-23. doi: 10.1016/j.cub.2005.03.049.
8. Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R. The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proc Natl Acad Sci USA. 2008;105:12539-44. doi: 10.1073/pnas.0801174105.
9. Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, Silva AJ, O'Dell TJ, Colicelli J. The RAS effector RIN1 modulates the formation of aversive memories. J Neurosci. 2003;23:748-57.
10. Goi T, Senda K, Yamaguchi A. Expression of RIN1 gene in gastric and colorectal cancers. Nihon Geka Gakkai Zasshi. 2001;102:783.
11. Morikawa J, Li H, Kim S, Nishi K, Ueno S, Suh E, Dougherty E, Shmulevich I, Shiku H, Zhang W, Kobayashi T. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17) (q22;q12) (PML/RARalpha). Int J Oncol. 2003;23:617-25.
12. Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J. RIN1 is a breast tumor suppressor gene. Cancer Res. 2007;67:11510-6. doi: 10.1158/0008-5472.CAN-07-1147.
13. Senda K, Goi T, Hirono Y, Katayama K, Yamaguchi A. Analysis of RIN1 gene expression in colorectal cancer. Oncol Rep. 2007;17:1171-5.
14. Tomshine JC, Severson SR, Wigle DA, Sun Z, Beleford DA, Shridhar V, Horazdovsky BF. Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem. 2009;284:26331-9. doi: 10.1074/jbc.M109.033514.
15. Chetcuti A, Aktas S, Mackie N, Ulger C, Toruner G, Alkan M, Catchpoole D. Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors. Pediatr Blood Cancer. 2011;57:950-7. doi: 10.1002/pbc.23003.
16. Fujioka M, Goi T, Hirono Y, Katayama K, Yamaguchi A. Cloning of a novel splicing variant of RIN1 and its expression in gastric and colon cancer. Oncol Res. 2009;17:593-9.
17. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993;72:2979-85.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8.
19. Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol. 2001;19:3210-8.
20. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341-53.
21. Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM, Park NH, Colicelli J, Gollin SM. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer. 2000;28:153-63.
22. Zainabadi K, Benyamini P, Chakrabarti R, Veena MS, Chandrasekharappa SC, Gatti RA, Srivatsan ES. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics. 2005;85:704-14.
23. Hu H, Milstein M, Bliss JM, Thai M, Malhotra G, Huynh LC, Colicelli J. Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration. Mol Cell Biol. 2008;28:1573-83. doi: 10.1128/MCB.01087-07.